Assurex: Study Shows GeneSight Statistically Improves Treatment Response In GAD

Assurex Health, a wholly-owned subsidiary of Myriad Genetics, Inc. (MYGN), announced new positive results for the GeneSight test in patients with Generalized Anxiety Disorder or GAD.

from RTT - Biotech http://ift.tt/2glgYr2
via IFTTT